18F-fluorodeoxyglucose positron-emitted tomography for predicting neurological outcome in hypoxic-ischemic encephalopathy

Brain Inj. 2021 Aug 24;35(10):1292-1300. doi: 10.1080/02699052.2021.1972154. Epub 2021 Sep 9.

Abstract

Background: 18F-fluorodeoxyglucose positron-emitted tomography (FDG-PET) is a promising yet unexplored functional neuroimaging tool in the study and prognosis of hypoxic-ischemic encephalopathy (HIE) after cardiac arrest or respiratory failure. The present study aimed to correlate clinical data and FDG-PET scans for both analysis and prognostic use. Methods: 24 patients from an intensive rehabilitation ward were retrospectively evaluated. Data collected included age, gender, cause of anoxic event, length of stay in acute and rehabilitation units, discharge destination, and evaluation at admission and discharge using three clinical scales to assess cognitive function, independence and disability. Subjects were identified as good and bad performers on the basis of quantitative analysis of FDG-PET scans with the Cortex ID software. The relation between glucose uptake reduction and neurological outcome was evaluated. Results: good and bad performers presented no statistically significant difference regarding demographical data and in-hospital length of stay. The two categories significantly differed for impairment and disability levels both at admission and at discharge from the inpatient rehabilitation unit. Conclusions: FDG-PET considerably facilitates the early identification of patients with HIE who will have poor neurological outcome and could inform planning for their rehabilitation and care.

Keywords: Hypoxia-ischemia; brain; positron-emitted tomography; prognosis; rehabilitation.

MeSH terms

  • Electrons
  • Fluorodeoxyglucose F18*
  • Humans
  • Hypoxia-Ischemia, Brain* / diagnostic imaging
  • Positron-Emission Tomography
  • Prognosis
  • Retrospective Studies

Substances

  • Fluorodeoxyglucose F18